Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Cancer Lett

Retrieve available abstracts of 10 articles:
HTML format

Single Articles

    July 2021
  1. LIU Q, Hua M, Zhang C, Wang R, et al
    NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1beta/Th1/IFN-gamma in acute myeloid leukemia.
    Cancer Lett. 2021 Jul 5. pii: S0304-3835(21)00299.
    PubMed     Abstract available

    May 2021
  2. TAVAKOLI SHIRAZI P, Eadie LN, Page EC, Heatley SL, et al
    Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia.
    Cancer Lett. 2021;512:28-37.
    PubMed     Abstract available

    April 2021
  3. LING Y, Xu N, Zhao K, Han L, et al
    Allogeneic hematopoietic cell transplant overcomes the poor prognostic value of CDKN2 deletion in adult B-lineage acute lymphoblastic leukemia.
    Cancer Lett. 2021;510:59-66.
    PubMed     Abstract available

  4. LEE DH, Kang SH, Choi DS, Ko M, et al
    Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells.
    Cancer Lett. 2021;510:37-47.
    PubMed     Abstract available

  5. LI Y, Li Y, Yin J, Wang C, et al
    A mitophagy inhibitor targeting p62 attenuates the leukemia-initiation potential of acute myeloid leukemia cells.
    Cancer Lett. 2021 Apr 13. pii: S0304-3835(21)00157.
    PubMed     Abstract available

    March 2021
  6. GLENEADIE HJ, Baker AH, Batis N, Bryant J, et al
    The anti-tumour activity of DNA methylation inhibitor 5-aza-2'-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress.
    Cancer Lett. 2021;501:172-186.
    PubMed     Abstract available

    August 2020
  7. YANG W, Liu S, Li Y, Wang Y, et al
    Pyridoxine induces monocyte-macrophages death as specific treatment of acute myeloid leukemia.
    Cancer Lett. 2020 Aug 26. pii: S0304-3835(20)30432.
    PubMed     Abstract available

  8. ZHANG LP, Lu AD, Wu J, Jia YP, et al
    Expanded activated autologous lymphocyte infusions improve outcomes of low- and intermediate-risk childhood acute myeloid leukemia with low level of minimal residual disease.
    Cancer Lett. 2020 Aug 20. pii: S0304-3835(20)30415.
    PubMed     Abstract available

    July 2020
  9. YANG H, Zhou H, Huang Z, Tao K, et al
    Induction of CML-specific immune response through cross-presentation triggered by CTP-mediated BCR-ABL-derived peptides.
    Cancer Lett. 2020;482:44-55.
    PubMed     Abstract available

    January 2020
  10. FORGIONE MO, McClure BJ, Eadie LN, Yeung DT, et al
    KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease.
    Cancer Lett. 2020;469:410-418.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.